Performance analysis of Clarus Therapeutics (BLUW)
Annual Return
Over the past 3 years, BLUW has had an average annual return of +7.97%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, BLUW has had an average annual return of +0.41%, underperforming the benchmark SPY, which returned +14.05% annual.
Since Feb 9, 2021, BLUW has had an average annual return of +0.17%, underperforming the benchmark SPY, which returned +14.90% annual.
| 2026 | 2025 | 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.49% | +7.17% | -5.40% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.19% | -0% | -0.58% | -0.19% | +0.09% | +0% | -0.49% | ||||||
| 2025 | +3.63% | -0.40% | +0.31% | +0.40% | +0.50% | +2.59% | +7.17% | ||||||
| 2021 | -0.69% | -0.39% | -0.20% | -0% | +0.30% | +0.70% | -30.15% | +35.82% | -5.40% |
Drawdown analysis of Clarus Therapeutics (BLUW)
The maximum drawdown for the BLUW was -32.15%, occurring on Aug 31, 2021. This drawdown has not yet recovered.
The current BLUW drawdown is -1.72%.
Since Feb 9, 2021 BLUW has experienced the following drawdowns:
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -32.15% | Aug 25, 2021 | 4 | Aug 31, 2021 | Ongoing | Ongoing | Ongoing |
| -3.74% | Feb 11, 2021 | 134 | Aug 24, 2021 | 1 | Aug 25, 2021 | 135 |